Clinical Trial Update: Clinical Study to Evaluate the Safety and Efficacy of γδ T Cells for the Prevention of Relapse After Allogeneic Transplantation in Patients With High-risk Acute Myeloid Leukemia [NA]

View source ↗

Summary

This clinical trial is evaluating the safety and efficacy of gamma-delta T cell therapy to prevent relapse after allogeneic transplantation in patients with hig…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia

Drugs mentioned

• gamma-delta T cell therapy (gamma-delta T cells)

Snippet

Sponsor: Donghua Zhang | Conditions: High-Risk Acute Myeloid Leukemia | NA | Status: RECRUITING